Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Aug. 31, 2019
Aug. 31, 2018
Aug. 31, 2017
Current      
Cash and cash equivalents $ 1,285,147 $ 1,727,184 $ 2,533,337
Marketable Securities (Note 21) 64,214 10,151  
Accounts receivable (Note 7) 273,145 265,751  
Inventory (Note 8) 127,396 87,233  
Prepaid expenses and deposit (Note 19) 68,927 193,732  
Total Current Assets 1,818,829 2,284,051  
Capital assets, net      
Patent (Note 9) 265,127 146,538  
Property & Equipment (Note 10) 591,263 1,237  
Total Non-Current Assets 856,390 147,775  
TOTAL ASSETS 2,675,219 2,431,826  
Current      
Accounts payable and accrued liabilities (Note 11) 136,411 35,785  
Due to a related party (Note 16) 48,096 7,855  
Total Current Liabilities 184,507 43,640  
TOTAL LIABILITIES 184,507 43,640  
STOCKHOLDERS' EQUITY      
Share Capital (Note 13) Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 78,787,134 common shares at August 31, 2019 and 75,533,471 common shares at August 31, 2018 78,787 75,533  
Additional paid-in capital (Note 13, 14) 26,172,453 22,095,682  
Accumulated Other Comprehensive Income   (14,247)  
Deficit (23,868,202) (19,768,782)  
Equity attributable to shareholders of the Company 2,383,038 2,388,186 2,767,831
Non-controlling Interest 107,674    
Total Stockholders' Equity 2,490,712 2,388,186 $ 2,767,831
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,675,219 $ 2,431,826